Drug Eluting Balloons Market Scope And Analysis

Report Code : TIPRE00003085
Category : Life Sciences

No. of Pages : 150

Buy Now

Drug-Eluting Balloon Market Scope and Analysis by 2031

Buy Now

Drug-Eluting Balloon Market Report Scope

Report Attribute	Details
Market size in 2021	US$ 762.56 Million
Market Size by 2031	US$ 3663.64 Million
Global CAGR (2023 - 2031)	17.5%
Historical Data	2021-2022
Forecast period	2023-2031
Segments Covered	By Product Type Peripheral Drug Eluting Balloons Coronary Drug Eluting Balloons Other Product Types By End User Hospitals Ambulatory Surgical Centers Cath Labs & Cardiac Centers
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Medtronic plc Becton Dickinson and Company Boston Scientific Corporation Cook Medical B Braun Melsungen AG Koninklijke Philips N V Opto Circuits Limited Terumo Corporation Biotronik SE Co KG Innvolution Healthcare Pvt Ltd

Drug-Eluting Balloon Market News and Recent Developments

The drug-eluting balloon market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for innovations, business expansion, and strategies:

In November 2023, OrbusNeich Medical Group Holdings Limited acquired Eucatech AG, a company based in Germany that specializes in the creation, production, and distribution of minimally invasive products for cardiovascular and endovascular therapy. Following this transaction, Eucatech AG will operate as a fully owned subsidiary of the Group. (Source: OrbusNeich Medical Group Holdings, 2023)
In October 2022, Cordis announced acquired MedAlliance, a company located in Switzerland known for its innovative drug-eluting balloons. This acquisition enables Cordis to potentially reach two million patients worldwide by 2027 with its SELUTION SLR (Sustained Limus Release) drug-eluting balloon. (Source: Cordis, 2022)

Drug-Eluting Balloon Market Report Coverage and Deliverables

The “Drug-Eluting Balloon Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:

Drug-eluting balloon market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
Drug-Eluting Balloon Market trends
Detailed PEST and SWOT analysis
Drug-Eluting Balloon market analysis covering key market trends, Global and regional framework, major players, regulations, and recent market developments
Drug-Eluting Balloon Market Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles